Suchergebnisse - (Subject:"Adalimumab")

PubPharm (1.669)

1

Vitiligo in a Patient Receiving Adalimumab for Idiopathic Uveitis

enthalten in: Turkish journal of ophthalmology | 2024

von Değirmenci, M. | Yalçındağ, F.

2

Clinical Efficacy of Biosimilar Switch of Adalimumab for Management of Uveitis

enthalten in: Ocular immunology and inflammation | 2024

von Murray, G. | Griffith, N. | Sinnappurajar, P. | +6

3

Efficacy and Safety of Adalimumab for Exacerbation or Relapse of Ocular Inflammation in Patients with Vogt-Koyanagi-Harada Disease : A Multicenter Study

enthalten in: Ocular immunology and inflammation | 2024

von Nakai, S. | Takeuchi, M. | Usui, Y. | +11

4

Adalimumab : A 'Maillon Faible' in the Treatment of Ulcerative Colitis?

enthalten in: Journal of Crohn's & colitis | 2024

von Roblin, X. | Paul, S.

CommentOn: J Crohns Colitis. 2024 Mar 1;18(3):341-348. - PMID 37691574

5

Defining a therapeutic range for adalimumab serum concentrations in the management of pediatric noninfectious uveitis, a step towards personalized treatment

enthalten in: Pediatric rheumatology online journal | 2023

von Dehoorne, J. | Groth, H. | Carlé, E. | +6

6

Tildrakizumab for the treatment of hidradenitis suppurativa in patients previously treated with adalimumab : a 30-month experience

enthalten in: Clinical and experimental dermatology | 2023

von Koszegi, B. | Wilson, A. | Stone, C. | +3

7

Real-world safety and effectiveness of adalimumab in patients with hidradenitis suppurativa : A 52-week analysis of a postmarketing surveillance study in Japan

enthalten in: The Journal of dermatology | 2023

von Hayashi, N. | Hayama, K. | Takahashi, K. | +5

8

Anti-TNF Biologicals Enhance the Anti-Inflammatory Properties of IgG N-Glycome in Crohn's Disease

enthalten in: Biomolecules | 2023

von Hanić, M. | Vučković, F. | Deriš, H. | +108

9

Guselkumab for hidradenitis suppurativa : a phase II, open-label, mode-of-action study

enthalten in: The British journal of dermatology | 2023

von Dudink, K. | Bouwman, K. | Chen, Y. | +11

CommentIn: Br J Dermatol. 2023 Apr 20;188(5):588-589. - PMID 36722365

10

Drug Survival of Anti Interleukin-17 and Interleukin -23 Agents after Adalimumab Failure in Hidradenitis Suppurativa : A Pilot Study

enthalten in: Acta dermato-venereologica | 2023

von Repetto, F. | Roccuzzo, G. | Burzi, L. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[167]